ATN 110 External Home Access Testing Results Dataset in Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States

Home Access testing results
Study Description
A pre-exposure prophylaxis (PrEP) demonstration project and Phase II safety study to obtain additional data on the safety of emtricitabine/tenofovir (FTC/TDF (Truvada®)) and evaluate patterns of use, rates of adherence, and patterns of sexual risk behavior among YMSM (inclusive of transgender women) who were provided with open label FTC/TDF and information on the safety and efficacy of PrEP from prior studies. This project also explored the feasibility and acceptability of implementing two different efficacious risk reduction interventions prior to provision of PrEP - Many Men, Many Voices (3MV) and Personalized Cognitive Counseling (PCC).
HIV-1 uninfected young men who have sex with men, ages 18-22 years

家庭接入测试结果
研究概况
本项目为暴露前预防（PrEP）示范项目与II期安全性研究，旨在获取恩曲他滨/替诺福韦（FTC/TDF（舒发泰®））安全性的补充数据，并评估开放标签给予FTC/TDF且获取既往研究中PrEP安全性与有效性信息的男男性行为青年（含跨性别女性）的用药模式、依从率及性风险行为特征。本项目同时探索了在提供PrEP前实施两种有效风险降低干预措施的可行性与接受度——众男众声（3MV）与个性化认知咨询（PCC）。
研究对象为18-22岁的HIV-1阴性男男性行为青年。